Press release
Asia Pacific Soliris Market to Witness Robust Expansion by 2025
In the last several years, Asia-Pacific market of Soliris developed rapidly, with an average growth rate of 34%. In 2017, Asia-Pacific Revenue of Soliris is nearly 350 M USD; the actual production is about 64 thousand units.
The major players in global Soliris market include
Alexion
Request to Buy Full Report@ https://www.qyresearch.com/settlement/pre/616e09a294f8168e4620126edf28c165,0,1
Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Soliris in these regions, from 2013 to 2025 (forecast), covering
China
Japan
Korea
India
Southeast Asia
Australia
Other
On the basis of product, the Soliris market is primarily split into
Plasma Exchange
Plasma Infusion
On the basis on the end users/applications, this report covers
PNH
AHUS
Other
Request Sample Copy of Report@ https://www.qyresearch.com/sample-form/form/356462/asia-pacific-soliris-market
About Us:
QY Research established in 2007, focus on custom research, management consulting, IPO consulting, industry chain research, data base and seminar services. The company owned a large basic data base (such as National Bureau of statistics database, Customs import and export database, Industry Association Database etc), expert’s resources (included energy automotive chemical medical ICT consumer goods etc.
Contact US
QY Research, INC.
17890 Castleton, Suite 218,
City of industry, CA – 91748
USA: +1 6262 952 442
China: +86 1082 945 717
Japan: +81 9038 009 273
India: +91 9766 478 224
Emails – enquiry@qyrsearch.com
Web – www.qyresearch.com
Expert News: www.qyresearch.com/expert/list
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Asia Pacific Soliris Market to Witness Robust Expansion by 2025 here
News-ID: 1173154 • Views: …
More Releases from QY Research, INC.
Global Semiconductor Silicon Wafer Market to Reach US$ 29.08 Billion by 2032, Dr …
Market Summary -
The global Semiconductor Silicon Wafer market was valued at US$ 17,020 million in 2025 and is projected to reach US$ 29,080 million by 2032, growing at a CAGR of 8.1% during the forecast period 2026-2032.
According to QY Research, the newly released report titled "Global Semiconductor Silicon Wafer Market Insights - Industry Share, Sales Projections, and Demand Outlook 2026-2032" delivers a comprehensive, data-driven assessment of the global silicon wafer…
Global Water Desalination Equipment Market to Reach US$ 10.93 Billion by 2032, D …
Market Summary -
The global Water Desalination Equipment market was valued at US$ 7,215 million in 2025 and is projected to reach US$ 10,930 million by 2032, growing at a CAGR of 6.2% during the forecast period 2026-2032.
According to QY Research, the newly published report titled "Global Water Desalination Equipment Market Insights - Industry Share, Sales Projections, and Demand Outlook 2026-2032" provides a comprehensive, data-driven evaluation of the global desalination equipment…
Global Syndiotactic Polystyrene Market to Reach US$ 162 Million by 2032, Driven …
Market Summary -
The global Syndiotactic Polystyrene (SPS) market was valued at US$ 111 million in 2025 and is projected to reach US$ 162 million by 2032, expanding at a CAGR of 5.6% during the forecast period 2026-2032.
According to QY Research, the newly released report titled "Global Syndiotactic Polystyrene Market Insights - Industry Share, Sales Projections, and Demand Outlook 2026-2032" provides a comprehensive, data-driven assessment of the global SPS market. The…
Global Hydroxypropyl Methacrylate Market to Reach US$ 156 Million by 2032, Suppo …
Market Summary -
The global Hydroxypropyl Methacrylate (HPMA) market was valued at US$ 144 million in 2025 and is projected to reach US$ 156 million by 2032, expanding at a CAGR of 1.2% during the forecast period 2026-2032.
According to QY Research, the newly released report titled "Global Hydroxypropyl Methacrylate Market Insights - Industry Share, Sales Projections, and Demand Outlook 2026-2032" provides a comprehensive, data-driven evaluation of the global HPMA market.…
More Releases for Soliris
Global Soliris Market Outlook 2025-2034: Trends, Innovations, And Future Outlook
The Soliris Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Soliris Market Size and Projected Growth Rate?
In recent times, the Soliris market has experienced significant growth. The market, which stood at $1,880.37 million in 2024, is anticipated to increase to $2,030.44 million…
Future Outlook of the Soliris Intravenous Market: Soliris Intravenous Trends and …
The global Soliris Intravenous Market was valued at approximately USD 3.5 billion in 2024 and is projected to reach around USD 6.8 billion by 2033, growing at a compound annual growth rate (CAGR) of about 7.5% from 2025 to 2033.
Request a sample copy of this report at: https://www.omrglobal.com/request-sample/soliris-intravenous-market
Soliris Intravenous Market Overview:
The Soliris Intravenous Market is experiencing steady growth driven by the increasing prevalence of rare and chronic diseases such as…
Soliris Drug Market: An In-Depth Analysis
The market size for Soliris (eculizumab) was estimated at approximately USD 4.2 billion in 2023 and is projected to reach around USD 9.7 billion by 2032, indicating a compound annual growth rate (CAGR) of 9.7% from 2024 to 2032.
Soliris Drug Market Overview
The Soliris (eculizumab) drug market plays a crucial role in the treatment of rare and life-threatening diseases, including paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS),…
Growing Prevalence Of Rare Blood Disorders To Drive Soliris Market Expansion: Ma …
How Will the Soliris Market Grow, and What Is the Projected Market Size?
The market size of Soliris has experienced significant growth in the past few years. Its expansion from $1,880.37 million in 2024 to $2,030.44 million in 2025 represents a compound annual growth rate (CAGR) of 8.0%. Factors contributing to this growth during the historic period include regulatory approvals, increased awareness of rare diseases, a rising demand for complement inhibition,…
Soliris Market Size, Growing Demand to 2033 Alexion
Soliris (eculizumab) is a groundbreaking monoclonal antibody used to treat rare, life-threatening diseases like paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), and generalized myasthenia gravis (gMG). It works by inhibiting the complement system, a part of the immune response that can attack healthy cells when overactivated. Approved by the FDA in 2007, Soliris was one of the most expensive drugs globally, reflecting its role in addressing ultra-rare conditions.…
Global Soliris Intravenous Market, Size, Share, Analysis Report & Forecast to 20 …
The global Soliris intravenous market is expected to grow at a significant CAGR during the forecast period (2021-2027). Eculizumab is a medicine that is used to treat paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS) and neuromyelitis optica. It is offered under the trade names Soliris and others. It appears to lower both the breakdown of red blood cells and the requirement for blood transfusions in patients with PNH,…
